Company Overview of Ritter Pharmaceuticals, Inc.
Ritter Pharmaceuticals, Inc., a biological therapeutics company, engages in the discovery, development, and commercialization of therapeutic treatments for gastrointestinal diseases and conditions. The company focuses on gastrointestinal physiology, metabolism, and gut adaptation associated with gastrointestinal diseases, including lactose intolerance, irritable bowel syndrome, crohn's disease, and ulcerative colitis. It develops RP-G28 for the treatment of lactose intolerance. The company was founded in 2004 and is based in Los Angeles, California.
1880 Century Park East
Los Angeles, CA 90067
Founded in 2004
Key Executives for Ritter Pharmaceuticals, Inc.
Ritter Pharmaceuticals, Inc. Key Developments
Similar Private Companies By Industry
|Ovalis, Inc.||United States|
|Albion Medical Holdings, Inc.||United States|
|Rockland Immunochemicals, Inc.||United States|
|Circulating Tumor Cell Inc.||United States|
|SynDevRx, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- Princeton, NJ | RGPPosted: Nov 27
- Princeton, NJ | RGPPosted: Oct 21
- Virginia | Quintiles TransnationalPosted: Dec 10
- Cambridge, MA | Biogen IdecPosted: Dec 10
Sponsored Financial Commentaries
To contact Ritter Pharmaceuticals, Inc., please visit www.ritterpharmaceuticals.com. Company data is provided by Capital IQ. Please use this form to report any data issues.